CLINICAL ROLE -
Can Biosimilars Reduce Specialty Spending?
David Lassen, chief clinical officer at Prime Therapeutics, discusses the potential long term impact from biosimilars on the specialty drug landscape.
Read More
Demonstrating Quality in Specialty Pharmacy
Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses the standards that illustrate quality in specialty pharmacy.
Colon Cancer, Multiple Myeloma Drug Development Highlights Week in Specialty Pharmacy
Top stories of the week on Specialty Pharmacy Times.
The Specialty Pharmacy Patient Experience
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses changes ahead for specialty pharmacy patients.
The Affordable Care Act and Specialty Pharmacy
Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses how health care reform has changed specialty pharmacy.
New Approach Found in Colorectal Cancer Treatment
Newly discovered epigenetic markers offer hope.
Colorectal Patients Should be Tested for Lynch Syndrome
Study finds most patients with Lynch syndrome are unaware they have the syndrome.
Gut Microbes May Influence Chemotherapy Side Effects
Chemotherapy drugs can convert gastrointestinal bacteria into toxic species that causes severe diarrhea.
Cancer Treatment Outcomes Influenced by Genetics
Anticancer medication response strongly linked to genetic ancestry.
How to Balance Requirements from Payers and Manufacturers
Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses how specialty pharmacies can best navigate complex reporting requirements from multiple entities.
Red Hot Cancer Killing Chili Peppers
Researchers seek to determine how compound from chili peppers kills prostate cancer cells.
Multiple Myeloma Drug Market Projected to Reach $9 Billion by 2021
Clinical outcomes expected to continue improving as new treatments arrive.
Priority Review to Multiple Myeloma, Lung Cancer Drugs Highlights Specialty Pharmacy Week in Review
FDA Grants Multiple Myeloma Drug Priority Review
Ixazomib is the first investigational oral proteasome inhibitor for relapsed and/or refractory multiple myeloma.
Biosimilars Poised to Impact Specialty Pharmacy
Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses the projected ramifications from the launch of biosimilars in the United States.
Experimental Multiple Myeloma Drug Safe and Effective in Trials
Daratumumab monotherapy slows disease progression a year after treatment.
Next Generation HIV Drug Combination Shows Improved Safety Profile
Experimental combination shows similar rates of HIV virologic suppression to Truvada.
Hope on the Horizon for Patients with Both Cancer and Diabetes
Tumors linked to high blood sugar can be successfully treated without affecting blood vessel growth.
HIV Testing Declines in Older Adults
Study finds substantial minority living with undiagnosed HIV infection.
Stigma of Medical Marijuana May Inhibit Usage
Study finds public opinion surrounding medical marijuana may influence treatment decisions.
FDA Grants Malignant Mesothelioma Treatment Orphan Drug Designation
Biologic therapy targets genetic defects found in various cancers.
Biosimilar Launch, Hepatitis C Drug Access Highlights Specialty Pharmacy Week in Review
FDA Approves Drug for Chemotherapy-Related Nausea
Varubi prevents nausea and vomiting associated with vomit-inducing cancer chemotherapy.
First Biosimilar Now Available in United States
Cancer therapy filgrastim-sndz (Zarxio) was initially approved on March 6, 2015.
FDA Grants Priority Review to Multiple Myeloma Drug
Elotuzumab is an immunostimulatory antibody combination therapy for patients who received one or more prior therapies.
Lung Cancer Treatment Granted Orphan Drug Status
Afatinib treats patients with advanced squamous cell carcinoma of the lung that progressed after chemotherapy.
Data Warehousing and Specialty Pharmacy
Paul Sipes, vice president of Spud Software, discusses how specialty pharmacies can benefit from the use of a data warehouse.
One in Four Patients Denied Early Treatment for Hepatitis C
Access to high cost curative antiviral HCV drugs remains a challenge for patients.
Vitamin D Levels May Influence Multiple Sclerosis Risk
Genetically reduced vitamin D levels could increase susceptibility to MS.
Researchers Improve Breast Cancer Risk Assessment Model
A significant increase in breast cancer development was found among a specific subset of women.